Evaluation of new or repurposed treatments for COVID-19: protocol for the phase Ib/IIa DEFINE trial platform.

Erin E GaughanTom QuinnAnnya BruceJean AntonelliVikki YoungJoanne MairAhsan AkramNik HiraniOliver KochClaire MackintoshJohn NorrieJames W DearKevin Dhaliwal

Published in: BMJ open (2021)

ISRCTN14212905, NCT04473053.

Keyphrases

coronavirus disease
sars cov
study protocol
phase iii
randomized controlled trial
phase ii
clinical trial
high throughput
respiratory syndrome coronavirus
open label
double blind